THC Therapeutics (THC Therapeutics) COGS-to-Revenue : 0.00 (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics COGS-to-Revenue?

THC Therapeutics's Cost of Goods Sold for the three months ended in Jul. 2023 was $0.00 Mil. Its Revenue for the three months ended in Jul. 2023 was $0.00 Mil.

THC Therapeutics's COGS to Revenue for the three months ended in Jul. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. THC Therapeutics's Gross Margin % for the three months ended in Jul. 2023 was N/A%.

THC Therapeutics COGS-to-Revenue Historical Data

The historical data trend for THC Therapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics COGS-to-Revenue Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

COGS-to-Revenue

Get a 7-Day Free Trial

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

THC Therapeutics COGS-to-Revenue Calculation

THC Therapeutics's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

THC Therapeutics's COGS to Revenue for the quarter that ended in Jul. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

THC Therapeutics (OTCPK:THCT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

THC Therapeutics's Gross Margin % for the three months ended in Jul. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

THC Therapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX